Learn More
Medchemexpress LLC Zefamenib | 2938995-50-5 | C31H35FN8O2 | 25 MG

Supplier: Medchemexpress LLC 25MGHY153714
Zefamenib is an effective selective brain membrane protein inhibitor with oral activity and a Menin inhibitor. It blocks the Menin-MLL interaction, leading to the degradation of the Menin protein. This compound is a weak hERG inhibitor, with an IC50 greater than 100 μM, and exhibits anti-tumor activity, making it suitable for cancer research, particularly for acute myeloid leukemia.
- Purity: 99.95%
- Molecular weight: 570.66
- Appearance: White to off-white solid
- Solubility in DMSO: 100 mg/mL
- Storage conditions: Powder at -20°C for 3 years or 4°C for 2 years; in solvent at -80°C for 6 months or -20°C for 1 month
- Weak hERG inhibitor with IC50 greater than 100 μM
- Exhibits anti-tumor activity and can be used in cancer research, such as for acute myeloid leukemia
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.